HEARTS in the Americas, the regional adaptation of the WHO Global HEARTS Initiative, is
being implemented in 24 countries and over 2000 primary healthcare facilities across the …

Background Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in
the Americas, and hypertension is the most significant modifiable risk factor. However …

Purpose of Review HEARTS in the Americas is the regional adaptation of Global Hearts, the
World Health Organization initiative for cardiovascular disease (CVD) prevention and …

Abstract In 2017, the World Health Organization (WHO) and Resolve to Save Lives
partnered with country governments and other stakeholders to design, test, and scale up the …

Cardiovascular diseases (CVD), principally ischemic heart disease (IHD) and stroke, are the
leading causes of death (18. 6 million deaths annually) and disability (393 million disability …

Hypertension is the leading risk factor for cardiovascular disease (CVD) worldwide. Despite
the availability of effective antihypertensive medications, the control of hypertension at a …

Abstract The World Health Organization (WHO) Global Hearts Initiative offers technical
packages to reduce the burden of cardiovascular diseases through population‐wide and …

Million Hearts is a national initiative co-led by CDC and the Centers for Medicare & Medicaid
Services that aims to prevent 1 million heart attacks, strokes, and other related acute …

Global Hearts is the flagship initiative of the World Health Organization to reduce the burden
of cardiovascular diseases, the leading cause of death and disability worldwide. HEARTS in …

Globally, cardiovascular diseases (CVDs) are the leading cause of death. Viewed as a
threat to the global economy, the United Nations included reducing noncommunicable …